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Action of Retinoids on Embryonic and Early Postnatal
Testis Development
ANDREA S. CUPP, JANNETTE M. DUFOUR, GRACE KIM, MICHAEL K. SKINNER,
AND KWAN HEE KIM
Center for Reproductive Biology, Department of Genetics and Cell Biology and Department of
Biochemistry and Biophysics, Washington State University, Pullman, Washington 99164-4231
ABSTRACT
The current study investigates the hypothesis that retinoids have
a role in embryonic testis development. The action of retinoids on
testis development and the expression of retinoic acid receptors
(RARa, RARb, RARg) were examined. In embryonic day 13 (E13; plug
date 5 E0) testis organ cultures an RAR-selective agonist and all-
trans retinoic acid completely inhibited seminiferous cord formation.
In contrast, an RARa-selective antagonist had no effect. RT-PCR
demonstrated that RARa messenger RNA (mRNA) was expressed at
all developmental time points evaluated, which included embryonic
day 14 (E14) through postnatal day 30 (P30). Expression of RARb
mRNA was present at E15 through P2, whereas RARg mRNA was
expressed at E18 through P2. Cellular localization of receptors by
immunohistochemistry indicated that RARa was localized to the in-
terstitium at E18 and to the seminiferous cords by P0. RARb and
RARg were detected in both interstitium and cords at E16 and by E18
were mainly expressed in the cords. At P0 RARb and RARg were
localized to the germ cell populations. To examine retinoid actions, the
growth of P0 testis cultures were investigated. Interestingly, retinol
and retinoic acid did not inhibit growth of P0 testis cultures but did
inhibit the action of growth stimulators. Retinoic acid inhibited FSH,
EGF, and 10% calf serum stimulated growth in P0 testis cultures. The
hypothesis tested was that the inhibitory effects of retinoids on P0
testis growth may be mediated through the growth inhibitor, trans-
forming growth factor-b (TGFb). The action of retinoids on TGFb
mRNA expression was examined in P0 testis cultures. Retinoic acid
stimulated TGFb3 mRNA expression within 24 h and increased ex-
pression of TGFb1 and TGFb2 after 72 h. Retinol increased expres-
sion of TGFb1 and TGFb2 but not TGFb3 after 72 h of treatment.
These observations indicate that retinoic acid can influence seminif-
erous cord formation and testis growth. The inhibitory actions of
retinoids may in part be mediated through increased expression of
TGFb isoforms. (Endocrinology 140: 2343–2352, 1999)
THERE ARE TWO critical processes that occur in theembryonic testis to ensure successful testis develop-
ment. The first is the process of seminiferous cord formation
that occurs at embryonic 13.5 (E13.5) (E0 5 plug date) in the
rat. The formation of cords involves Sertoli cell mesenchymal
to epithelial transition (1, 2) and an aggregation of Sertoli and
germ cells within the differentiating gonad. Migration of cells
(presumably pre-peritubular cells) from the adjacent meso-
nephros to surround the Sertoli and germ cell aggregates
completes the compartmentalization of the testis into sem-
iniferous cords and interstitium (3, 4). Seminiferous cord
formation is a crucial process because this is the first mor-
phological indicator of sex determination in most mammals.
Seminiferous cord formation has been determined to be go-
nadotropin independent (5). Therefore, cord formation and
testis development must rely on factors produced by cells
within the developing testis. Few factors have been deter-
mined to influence seminiferous cord formation. Both inte-
grin subunit a 6 (6) and lectin (7) have been demonstrated
to be involved in the early steps of cell aggregation leading
to cord formation.
Retinoic acid is also a factor that has been determined to
effect seminiferous cord formation during embryonic testis
development (8). Treatment of testis organ cultures with
retinoic acid at high concentrations (9) disrupt formation of
the basement membrane and perturb the formation of sem-
iniferous cords. Cellular localization of the messenger RNA
(mRNA) encoding receptors for retinoic acid have been in-
vestigated in the whole embryo (10). Retinoic acid receptor
(RAR)a transcripts were shown to be expressed ubiquitously
in the gonads after cord formation in mice. Expression of
RARb transcript was restricted to the proximal mesenchyme
of the genital tubercle, close to the urogenital sinus (10). The
RARg expression was absent from the proximal mesen-
chyme of the genital tubercle and present in the distal tip.
These results suggest a potential role for RARs in embryonic
testis development.
After seminiferous cord formation, a second process oc-
curs that involves a sex-specific increase in growth of the
testis. All populations of cells within the testis proliferate
after seminiferous cord formation, and by E15, the testis is
twice the size of the ovary from the same age animals (11).
This process of embryonic testis growth is critical because
adequate numbers of somatic cells are necessary to support
spermatogenesis in the adult (12). Much of embryonic testis
growth occurs before the acquisition of gonadotropin recep-
tors (13) and may be attributed to paracrine factors produced
locally in the testis. Recently TGFa has been shown to be
important for embryonic testis growth subsequent to cord
formation (14). Other potential regulators of embryonic testis
growth are basic FGF (15), FGF-8 (16), and TGFb (17, 18, 19,
20), which are all produced by cells within the embryonic
testis after cord formation.
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Retinoic acid has been reported to interact with TGFb to
affect cell proliferation and differentiation in other tissues
(21). In the prostate, retinoic acid has been demonstrated to
inhibit cell growth and proliferation through the stimulation
of TGFb expression (22). Therefore, retinoids have the po-
tential to regulate differentiation of the testis (seminiferous
cord formation) as well as embryonic testis growth. The
objective of the current study was to investigate the action of
retinoids and expression of RARs at two periods during testis
development. The first critical period was during testis mor-
phogenesis (cord formation) around E13. The second period
was just after birth at P0 when cells are mitotically active. The
hypothesis tested was that retinoids are critical for both
seminiferous cord formation and subsequent embryonic
testis growth.
Materials and Methods
Organ cultures
Timed pregnant Sprague Dawley rats were obtained from Charles
River (Wilmington, MA). Plug date was considered to be E0. Embryonic
day 13 (E13) gonads were dissected out with the mesonephros. The
organs were cultured in drops of medium on Millicell CM filters (Mil-
lipore Corp., Bedford, MA) floating on the surface of 0.4 ml of CMRL
1066 media (Gibco BRL, Gaithersburg, MD) supplemented with peni-
cillin-streptomycin, insulin (10 mg/ml) and transferrin (10 mg/ml). An-
tibodies and factors were added directly to the culture medium. The
medium was changed every day. E13 gonad 1 meso- nephros were
typically kept for 3 days by which point cords were well developed.
Images of whole organs were obtained by an image analysis system
(Pixera, Pixera Corp., Los Gatos, CA) (22).
Genomic DNA isolation and PCR for SRY
To determine the sex of E13 embryos PCR for SRY was conducted on
each embryo. Embryonic tails were collected to isolate genomic DNA by
standard procedures. Briefly, the tissue was homogenized through a
25-gauge needle in digestion buffer (100 mm NaCl; 10 mm Tris, pH 8;
25 mm EDTA; 0.5% SDS), and treated with proteinase K (0.15 mg/ml)
for at least 4 h at 60 C. The samples were then extracted twice with an
equal volume of phenol: chloroform: isoamyl alcohol (25:24:1), and once
with chloroform: isoamyl alcohol. The DNA was then precipitated by
adding 1/10 volume 7.5 m ammonium acetate and 3 volumes cold
ethanol and collected by centrifugation at 4 C for 30 min after an hour
incubation at 280 C. Pellets were dried and resuspended in 10 ml dis-
tilled H2O. PCR was performed using 1 ml of genomic DNA with primers
to SRY. The sequences of the SRY primers are: 59 CGGGATCCATGT-
CAAGCGCCCCATGAATGCATTTATG 39 and 59 GCGGAATTCACTT-
TAGCCCTCCGATGAGGCTGATAT-39. PCR was performed using an
annealing temperature of 55 C for 30 cycles to yield a product of 240
bp (23).
Testicular cell culture and growth assay
To generate a testicular culture from P0 testis, the tunica was removed
and the testis digested with 0.125% trypsin, 0.1% EDTA, and 0.02 mg/ml
DNase in HBSS, for 15 min at 37 C. The trypsin was inactivated with 10%
calf serum. The samples were triturated with a pipette tip and washed
twice in 1 ml HBSS. The pellet was resuspended and either used in
growth assays immediately or placed in 100-mm plates in F12 media
supplemented with 10% bovine calf serum until confluent (approxi-
mately 2 days). For growth assays cells were plated at a 25% confluence
in 24-well plates and allowed to settle overnight in DMEM media with-
out thymidine. Media was replaced the next day and cells were treated
for 24 h with different hormones or growth factors. Media was removed
after the 24-h treatment period and media containing tritiated thymidine
(10 mCi/ml) was placed on cells for 5–6 h. After 5–6 h media was
discarded and cells were either frozen or processed using the tritiated
thymidine assay. Briefly, solution of 0.5 m NaH2P043 (pH 7.3; 500 ml) was
added to each well and cells were sonicated. Half of the sonicated cells
were placed on DE-81 filters on a manifold and a vacuum was applied.
After three washes with the NaH2P04 buffer the filters were dried, placed
in counting vials with 5 ml of scintillation fluid and counted. The re-
maining sonicate was used for DNA assays to normalize number of cells
per well (22).
DNA assay
To determine the DNA content of each well of P0 testis cultures, the
remaining sonicate from the growth assay was combined with 100 ml
ethidium bromide buffer (EBB, 20 mm NaCl, 5 mm EDTA, 10 mm Tris,
pH 7.5). DNA content was determined fluorometrically with ethidium
bromide as previously described (22). Briefly, 0.25 nm ethidium bromide
and 100 U/ml heparin in EBB were added to each sample, vortexed, and
incubated for 15 min at room temperature. Fluorescent emission was
measured and quantified by using a standard curve with calf thymus
DNA from 0.5 mg to 6 mg DNA (22).
RNA isolation and RT-PCR
Total RNA was obtained using Tri Reagent (Sigma Chemical Co.).
Briefly, tissue or cells were lysed in Tri Reagent (1 ml/50–100 mg tissue
or 1 ml/100 mm of culture plate). After adding 0.2 ml chloroform/ml
Tri Reagent, the mixture was centrifuged at 12,000 3 g for 15 min at 4
C, the colorless upper aqueous phase was transferred to a fresh tube, and
0.5 ml isopropanol/ml Tri Reagent was added to pellet the RNA. RT was
performed using MMLV-reverse transcriptase under standard condi-
tions. RT-PCR was performed at 55 C annealing temperature for 30
cycles. The primer sequences and procedures were from previously
reported experiments (24). The primer sequences are as follows: RARa:
59 CAGATGCACAACGCTGGC 39 and 5 9CCGACTGTCCGCTTAGAG
39; RARb: 59ATGCTGGCTTCGGTCCTC 39 and 59 CTGCAGCAGTG-
GTGACTG 39; RARg: 59 GTGGAGACCGAATGGACC 39 and 59 GA-
CAGGGATGAACACAGG 39.
Quantitative RT-PCR
Quantitative RT-PCR (QRT-PCR) procedures were performed as pre-
viously published (22). Briefly, total RNA (1 mg) was reverse transcribed
using the specific 39 primers. Plasmid DNA’s containing subclones of
interest were used to generate standard curves from 1 ng/ml to 10 pg/ml
each containing 10 ng/ml Bluescript carrier DNA. Identical 10-ml ali-
quots of each sample or standard were used for PCR amplification. At
least 0.25 mCi of 32P-labeled dCTP was included in each sample during
amplification. Specific PCR products were quantitated on 4–5% poly-
acrylamide gels. The gels were exposed to a phosphor screen for 8–24
h, followed by quantification of specific bands on a PhosphorImager
(Molecular Dynamics, Inc.) and analyzed with Image Quant. Equivalent
steady-state mRNA levels for each gene were determined by comparing
each sample to the appropriate standard curve. All gene expression data
were normalized for 1B15 (cyclophilin) mRNA. Optimal cycle number
for amplification was determined for each assay to achieve maximum
sensitivity while maintaining linearity. The sensitivity of each quanti-
tative PCR assay is below 1 fg with intraassay variabilities of 6–15%.
Primers used for the QRT-PCR were as follows: TGFb1, 59,59-TCG ATT
TTG ACG TCA CTG GAG TTG T-39 and 39,59-GGG GTG GCC ATG AGG
AGC AGG-39; TGFb2, 59-59-CCG CCC ACT TTC TAC AGA CCC-39 and
39, 59-GCG CTG GGT GGG AGA TGT TAA-39; TGFb3, 5 prime 59 TGC
CCA ACC CGA GCT CTA AGC G-39, 39,59-CCT TTG AAT TTG ATC
TCC A-39; cyclophilin, 59,59-ACA CGC CAT AAT GGC ACT GG-39 and
39,59-ATT TGC CAT GGA CAA GAT GCC-39 (22).
Embedding, histology, and immunohistochemistry
Tissues were fixed in Histochoice (Amresco, Solon, OH) and embed-
ded in paraffin according to standard procedures (22). The tissue sec-
tions (3 mm) were deparaffinized, rehydrated, microwaved, and blocked
in 10% goat serum for 15 min at room temperature. Immunohistochem-
istry was performed as described previously (25, 26). The RARa anti-
body was an anti-RARa peptide antibody (Santa Cruz Biotechnology,
Inc. (SCB), Santa Cruz, CA) raised against amino acids 443–462 (CSPSL-
SPSSNRSSPATHSP) of human RARa (which is 100% homologous to rat
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RARa, unpublished data). The RARb antibody was an anti-RARb pep-
tide antibody (SCB) raised against amino acids 430–447 (SISPSSVENS-
GVSQSPLVQ) of human RARb. The RARg antibody was an anti-RARg
peptide antibody (SCB) raised against amino acids 436–454
(CSSEDEVPGGQGKGGLKSPA) of human RARg. The RARa antibody
was diluted 1:200 in 10% goat serum, and he RARb and g primary
antibodies were diluted 1:50 in 10% goat serum. As a negative control,
serial sections were put through the same procedure without any pri-
mary antibody. Additional negative control sections were incubated
with 503–1003 excess of synthetic immunizing peptide and the anti-
RARa, anti-RARb, or anti-RARg antibody. The biotinylated goat anti-
rabbit secondary antibody (Vector Laboratories, Inc., Burlingame, CA)
was diluted 1:300. The secondary antibody was detected by using the
histo stain-SP kit (Zymed Laboratories, Inc., South San Francisco, CA)
and immunohistochemical images were digitized with a slide scanner
(Sprint Scan, Polaroid, Cambridge, MA).
Immunoblotting
Soluble proteins from six P0 testes were prepared as previously
described (26). The testes were homogenized and lysed in 1 ml of lysis
buffer (50 mm Tris-HCI, [pH 7.5], 250 mm NaCl, 0.1% Triton X-100, 50
mm NaF, 5 mm EDTA) containing a cocktail of proteinase inhibitors
(100 mg/ml phenylmethylsulfonyl fluoride, 10 mg/ml Aprotinin,
10 mg/ml leupeptin). Protein concentration was determined by the
method of Bradford (27) with BSA as the standard.
Fifty (RARa) or one hundred (RARb and g) micrograms of protein
were loaded on 8.5% SDS-polyacrylamide gels and subjected to elec-
trophoresis. This was repeated three times. The proteins were trans-
ferred to an Immobilon-P membrane (Millipore Corp.) to perform West-
ern blot analysis. The membranes were blocked with 5% blotto
(Carnation, Los Angeles, CA) in PBS for 1 h at room temperature and
then incubated with the appropriate primary antibody at a dilution of
1:200 in PBS/Tween-20 for 1 h. This was followed by incubation with
horseradish peroxidase-conjugated antirabbit IgG secondary antibody
at a dilution of 1:2500 in PBS/Tween-20 for 30 min. The proteins were
detected by the Enhanced Chemiluminescence (ECL) Western blotting
system (Amersham Corp., Arlington Heights, IL) (27).
Statistical analysis
All data were analyzed by a JMP 3.1 statistical analysis program (SAS
Institute, Inc., Cary, NC). All values are expressed as the mean 6 sem.
Statistical analysis was performed using one-way ANOVA. Significant
differences were determined using the Dunnett’s test for comparison to
controls and using the Tukey-Kramer honesty difference test for mul-
tiple comparisons. Statistical difference was confirmed at P , 0.05.
FIG. 1. E13 testis organ cultures treated with (A) ethanol control or with (B)-(D) 0.7 mM retinol. The retinol treatments (B), (C), and (D)
demonstrate the variability of seminiferous cord formation with this treatment. Organ cultures were treated daily at the time of media changes
with 0.7 mM retinol or with ethanol control. These are representative images from 24 testis pairs (n 5 24; 24 treated, 24 controls). M, Mesonephros;
T, testis. Magnification, 803.
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Results
Effect of retinoids and retinoid antagonists on seminiferous
cord formation
Embryonic day 13 (E13) testis organ cultures were used to
determine the effects of retinoids, retinoid agonists, and ret-
inoid antagonists on seminiferous cord formation. E13 testis
with mesonephros were cultured and placed on floating
filters. One of each testis pair was treated with retinoids or
retinoid antagonists while the other served as a control. Em-
bryonic testis organ cultures were treated daily for 3 days, at
which time the control testis formed seminiferous cords.
Retinol at a dose of 0.35 mm did not effect seminiferous cord
formation or embryonic testis organ culture morphology
(data not shown). However, when this dose was increased to
0.70 mm, there was an increase in seminiferous cord disrup-
tion but not a complete inhibition of seminiferous cords
(Fig. 1, B–D). Higher concentrations of retinol may be nec-
essary to cause seminiferous cord disruption. This confirms
that the retinoic acid metabolite of retinol is likely the effec-
tive form of retinoid. To examine the effects of retinoic acid
on seminiferous cord formation the E13 testis organ cultures
were treated with 0.1 mm or 1 mm all trans-retinoic acid. The
0.1 mm dose of retinoic acid (Fig. 2, B and C) did not affect
seminiferous cord formation, but the 1 mm concentration
completely inhibited cord formation in E13 testis organ cul-
tures (Fig. 3B). Therefore, these data confirm previous re-
ports (8) and provide novel data that demonstrate that reti-
noic acid can perturb formation of seminiferous cords in E13
testis organ cultures in a dose-dependent manner.
To extend the results of the previous experiments (8), a
specific RAR agonist (28) and RARa antagonist (28) were
used to treat E13 testis organ cultures. The RAR specific
agonist when treated at 0.1 mm perturbed cord formation
(Fig. 3D) to a greater extent than either retinol or retinoic acid
treated at similar doses. In contrast, a specific antagonist to
RARa did not have any effect on seminiferous cord forma-
tion in E13 testis organ cultures (data not shown). These
novel results demonstrate that the RAR may be important for
early testis differentiation and excessive amounts of retinoic
acid are disruptive to testis morphogenesis.
Expression of mRNA for RARs during testis development
To determine expression of mRNAs for RARs during testis
development, RT-PCR for RARa, RARb, and RARg was con-
ducted in E14 through P30 testis sections. Expression of
mRNA for RARa (Fig. 4A) was present in the testis during
developmental periods between E14 and P30. Expression of
mRNA for RARb (Fig. 4B) and RARg (Fig. 4C) appeared to
be more transiently expressed during testis development.
Expression of mRNA for RARb (Fig. 4B) was detected in
testis from rats at E15, E18-P2, and then at P10. The expres-
sion of mRNA for RARg (Fig. 4C) was present in testis from
E18 through P2 (similar to RARb) and then at P5 and P30.
These observations suggest that the mRNAs for receptors of
FIG. 2. E13 testis organ cultures treated with (A) ethanol control or
with (B)-(C) 0.1 mM all-trans retinoic acid The all-trans retinoic acid
treated organ cultures (B) and (C) demonstrate the variability of
seminiferous cord formation with this treatment. Organ cultures
were treated daily at the time of media changes with 0.1 mM all-trans
retinoic acid or with ethanol control. These are representative images
from 36 testis pairs (n 5 36, 36 treated, 36 were controls). Magnifi-
cation, 803.
2346 RETINOIDS AND TESTIS DEVELOPMENT Endo ² 1999
Vol 140 ² No 5
  
retinoic acid are present during embryonic development and
that expression of mRNAs for RARb and RARg appear to be
developmentally regulated during testis development.
Protein expression and cellular localization of RARs during
embryonic testis development
Antibody specificities for anti-RARa, RARb, and RARg
were determined on proteins isolated from P0 testis by West-
ern blot analysis. Two bands (54 and 50 kDa) were detected
for RARa (Fig. 5). One band was detected (55 kDa) for both
RARb and RARg. RARb and RARg also had a minor band
detected at approximately 45 kDa (data not shown). These
results are consistent with previously published results for
the receptors in mouse and human (29–31).
The cellular localization of RAR protein expression was
examined by immunohistochemistry for RARa, RARb, and
RARg using testis sections from E14, E16, E18, and P0 testis
(Fig. 6, A–O). Expression of RARa protein in E16 testis was
variable (Fig. 6B). Some sections had low signal at the edge
of the seminiferous cords, while others had greater staining
within the interstitium. By E18, cells within the interstitium
stained positive for RARa including cells surrounding the
seminiferous cords that are presumed to be peritubular cells
(Fig. 6C). Low levels of staining were detected in selected
cells within the cords. At P0, germ cells within the cords
stained positive for RARa (Fig. 6D).
Expression of protein for RARb was detected in both in-
terstitial cells and cells within the cords at E16 (Fig. 6G). In
contrast, at E18 only cells within the cords stained positive
for RARb (Fig. 6M). The positive staining was in both Sertoli
and germ cells. By P0, positive staining for RARb was de-
tected in the germ cells of the seminiferous cords (Fig. 6, I–J).
The Sertoli cells had little or no positive staining for RARb
at P0. The expression and cellular localization of protein for
RARg was similar to that of RARb at E16, E18, and P0 (Fig.
6, L–O). At E16, both the interstitium and cords stained
positive for RARg, whereas at E18 only the cells within the
seminiferous cords stained positive for RARg. At P0,
the highest level of expression for RARg was detected in the
germ cells. Therefore, by P0 of testis development expression
FIG. 3. E13 testis organ cultures treated with (A) ethanol control, (B) 1 mM all-trans retinoic acid, (C) ethanol control or (D) 0.1 mM RAR agonist
(CH57). Organ cultures were treated daily at the time of media changes with 0.1 mM RAR agonist, 1 mM all-trans retinoic acid or with ethanol
control. These are representative images from 14 testis pairs (n 5 14; 14 treated, 14 controls). Magnification, 803.
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of RARa, RARb, and RARg was present within the germ cell
population.
Effect of retinoids on early testis growth
The effect of retinoic acid and retinol on whole P0 testis
growth was examined with testicular cultures from P0 rats.
FSH, EGF, and 10% calf serum were used as positive controls
because all of these reagents stimulate growth of P0 testis
cultures (Fig. 7). Interestingly, retinol or retinoic acid treat-
ment alone had no effect on growth of whole P0 testis cul-
tures (Fig. 7, A and B). Retinol and retinoic acid inhibited EGF
(Fig. 7A) and 10% calf serum stimulated growth (Fig. 7B). In
addition, retinoic acid inhibited FSH stimulated growth
(Fig. 7A). Thus, the current study demonstrates that retinoids
influence the ability of FSH, EGF, and 10% calf serum to
stimulate whole P0 testis growth.
Effects of retinoids on expression of mRNA for TGFb
The mechanism of how retinoids may regulate cell growth
in P0 testis cultures was investigated by measuring expres-
sion of TGFb isoforms through QRT-PCR. A representative
autoradiogram of a QRT-PCR gel is shown in Fig. 8. Previous
results (20) have demonstrated that TGFb inhibits EGF and
10% calf serum stimulated growth in P0 testis cultures. Testis
cell cultures from P0 rats were treated with retinol (0.35 mm)
or retinoic acid (0.1 mm), and mRNA was collected after 24
and 72 h of treatment. Retinol at 0.35 mm did not induce
changes in expression of mRNA for any TGFb isoforms after
24 h of treatment (Fig. 9C). In contrast, retinoic acid stimu-
lated TGFb3 mRNA levels after 24 h of treatment. Interest-
ingly, retinol increased expression of TGFb1 and TGFb2 after
72 h of treatment. This was in contrast to retinoic acid, which
increased expression of mRNA for all three TGFb isoforms
after seventy two hours of treatment (Fig. 9, A–C).
FSH did not affect expression of any TGFb isoforms. FSH
given in combination with retinol appeared to suppress the
stimulatory effects of retinol on TGFb1 and TGFb2 after 72 h
of treatment. In contrast, FSH given in combination with
retinoic acid suppressed the stimulatory effects of retinoic
acid on mRNA expression for TGFb1, but not TGFb2 or
TGFb3 after 72 h of treatment. Interestingly, FSH treatment
in combination with retinoic acid also suppressed retinoic
acid induced expression of TGFb3 after 24 h of treatment
(Fig. 9). These observations suggest that retinoic acid in-
creases expression of TGFb isoforms that have previously
been shown to inhibit cellular proliferation and growth. FSH
when administered in combination with retinol or retinoic
acid is capable of suppressing retinoid increased mRNA
expression of specific TGFb isoforms after 24 and 72 h of
treatment. Therefore, retinoid inhibition of P0 testis growth
is likely through indirect actions on the expression of TGFb
isoforms.
Discussion
Retinoic acid is one of the few factors that has been de-
termined to perturb seminiferous cord formation in E13 testis
organ cultures at high doses (8). This disruption of cord
formation was proposed to occur due to inhibition of laminin
production or production of factors that form the basement
membrane. Excess retinoic acid may also disrupt events as-
sociated with Sertoli cell mesenchymal to epithelial cell tran-
sition that occurs early in testis development. Retinoic acid
is required for normal morphogenesis of the embryo and
cannot be synthesized de novo (32). However, detrimental
effects have been observed when retinoic acid is present at
concentrations higher than optimal levels (33). The range of
FIG. 5. Western blot analysis with RARa, RARb, and RARg antibod-
ies in P0 testis extracts. The bands for RARa are approximately 54
and 50 kDa, whereas the band for RARb and RARg is approximately
55 kDa. Molecular markers for 43 kDa and 68 kDa are shown on the
left.
FIG. 4. RT-PCR for (A) RARa, (B) RARb, and (C) RARg mRNA ex-
pression from E14-P30 during testis development. These data are
representative of two different PCR reactions for each time period.
Sizes of expected PCR fragments are: RARa 5 397 bp; RARb 5 470
bp; RARg 5 521 bp.
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retinoic acid previously reported in embryos is 20 nm to 150
nm (34, 35). Receptors for retinoic acid have not been local-
ized to specific cells within the embryonic testis. In whole
embryos, mRNA for RARa, RARb, and RARg have been
localized to the gonad around the time of cord formation (10).
The current study was designed to determine the cellular
expression of the retinoic acid receptors and action of reti-
noids during embryonic testis development. While 1 mm RA
has been demonstrated to inhibit seminiferous cord forma-
tion, the actions of retinol, lower doses of RA, and specific
RAR selective agonist on seminiferous cord formation have
not been evaluated. Observations confirm previous research
as well as demonstrate novel data on the dose dependent
effects of retinol, all-trans retinoic acid and a RAR-selective
agonist on seminiferous cord formation. All-trans retinol is a
circulating form of retinoid in the bloodstream and can be
converted to either all-trans retinoic acid or to 9-cis retinoic
acid in the tissue (36). All-trans retinoic acid binds prefer-
entially to the RARs. In contrast, 9-cis retinoic acid binds to
and activates both RAR and RXR (36). In the present study,
all forms of retinoids caused disruption or disorganization of
seminiferous cord formation. All-trans retinoic acid at con-
centrations of 1 mm and 0.1 mm RAR-selective agonist had the
greatest effect on inhibition of cord formation. This infor-
FIG. 6. Immunohistochemistry for RARa at (A) E14, (B) E16, (C) E18, and (D, E) P0; RARb at (F) E14, (G) E16, and (H) E18 and I, J P0; RARg
at (K) E14, (L) E16, (M) E18, and (N, O) P0. Magnification (A–D, E–I, K–N), 4003; E, J, O, 1,0003. This experiment was repeated three times
for each developmental time point.
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mation is important because the RAR selective agonist dem-
onstrates that seminiferous cord formation disruption may
be through the RAR and not RXR. It is not surprising that
retinol did not have as dramatic effect on cord formation
because conversion of retinol is necessary to produce retinoic
acid. Therefore, it was necessary to increase the amount of
retinol added to the organ cultures to elicit a similar effects
as either all-trans retinoic acid or the RAR-selective agonist.
The current study used RT-PCR and immunohistochem-
istry to determine the expression patterns and localization of
RARs. RT-PCR demonstrated that expression of RARa
mRNA was present during all developmental periods eval-
uated (E14-P30). RARa mRNA was the only RAR mRNA
present around the time of seminiferous cord formation.
Therefore, any action of retinoids may be elicited through
RARa at this developmental period. However, RARa protein
was not expressed in E14 testis and did not appear until E16.
This may be due to a translational control that has been
reported previously in adult testis (26). This suggests that
RARs may not participate in the normal process of seminif-
erous cord formation. Previous observations have also dem-
onstrated that retinoids are capable of up regulating the
expression of RARa (37, 38). This may provide a potential
explanation of how treatment of retinoic acid could inhibit
seminiferous cord formation in E13 testis organ cultures.
Further investigation is necessary to determine whether
RARa expression can be up-regulated in E13 organ cultures.
Cellular localization of RARa protein in the testis was dem-
onstrated to be in the interstitium at E16 and E18. By P0 of
testis development, RARa protein was in the germ cells.
Therefore, RARa may be important after E16 to regulate the
growth and differentiation of the interstitial and germ cells.
The phosphorylation state and expression of the protein are
both important to determine if RARa is capable of binding
retinoic acid in the embryonic and postnatal testis. Previous
reports have demonstrated that posttranslational modifica-
tion can influence the activity of RARa in several different
tissues (37).
In contrast to RARa, the mRNA for both RARb and RARg
were transiently expressed during testis development. This
suggests that there is potential regulation of these two re-
ceptors during testis development. RARb mRNA is present
at E15 while both RARb and g are present in the embryonic
testis from E18 through P2. This is a time during testis de-
velopment when germ cell populations have undergone mi-
totic arrest and have stopped cell division (39). The expres-
sion of mRNA for RARb present at E15 occurs before protein
expression at or around E16 of testis development. There is
a discrepancy in the first appearance of mRNA for RARg
(E18) and the appearance of RARg protein at E16. One pos-
sible explanation is that mRNA expression for RARg occurs
before E14. By P0 of testis development, all receptors for
retinoic acid are localized to the germ cell population. This
cellular localization of the RARs suggests a potential regu-
lation of germ cell differentiation and proliferation within the
perinatal developing testis.
The effects of retinoids on cell growth was examined in
the current study with a mixed population of testicular
cells from P0 rats. Retinoids alone did not influence cell
FIG. 8. Autoradiogram of a representative QRT-PCR gel for TGFb2.
Lanes 1–5 represent TGFb2 standard or cyclophilin at 0.5 pg, 50 pg,
500 pg, and 5 ng. Lanes 6 through 17 represent P0 testis samples.
FIG. 7. Effects of retinol and all-trans
retinoic acid on (A) EGF and FSH stim-
ulated and (B) 10% calf serum stimu-
lated P0 testis growth. Results are pre-
sented as percentage of control and
represent three to four individual ex-
periments in triplicate. Different super-
script letters for each mean represent a
statistical differences at P , 0.05.
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growth. However, retinol and all-trans retinoic acid in-
hibited thymidine incorporation in EGF and 10% calf se-
rum stimulated cells. In addition, retinoic acid inhibited
FSH stimulated growth. It is interesting that retinoid treat-
ment alone did not inhibit growth. At P0, germ cells in vivo
are the only cell population within the testis that is not
actively proliferating. Because receptors for RARs are
present in germ cells at P0, retinoids may contribute to the
growth arrest of germ cells. Further treatment of P0 testis
cultures with retinoids may not have inhibitory effects on
this cell population. However, stimulation of P0 testis cells
by FSH, EGF, and 10% calf serum may allow for progres-
sion of the cell cycle in germ cells when in culture. These
growth stimulators may cause the germ cells to resume
mitosis and allow for subsequent inhibition of germ cell
proliferation by retinoid treatment.
The inhibition of cell growth by retinoids is not novel to
the testis. Retinoic acid has been observed to prevent cell
growth in several other tissues. In the prostate, retinoic acid
inhibits cellular growth and proliferation by stimulating ex-
pression of mRNA and protein for all three isoforms of TGFb
(21). In addition, a monoclonal neutralizing antibody to all
isoforms of TGFb blocked the ability of retinoic acid to inhibit
growth (21). Therefore, it was proposed that retinoic acid
caused the inhibition of growth through increased or altered
expression of TGFb isoforms in P0 testis.
Retinoic acid increased expression of mRNA for TGFb3
within 24 h. After 72 h, TGFb1, TGFb2, and TGFb3 mRNA
expression was also elevated in retinoic acid treated cultures.
These results are similar to those demonstrated previously in
the prostate (21). In the prostate, up-regulation of mRNA for
TGFb2 and TGFb3 was greater and earlier than subsequent
increases in mRNA for TGFb1 by retinoic acid (20). In the
testis TGFb1 inhibits testis growth in embryonic and P0 testis
cultures (20). Therefore, regulation of cellular proliferation
by retinoic acid is potentially mediated through the expres-
sion of specific TGFb isoforms which in turn cause inhibition
of cellular proliferation.
Interestingly, retinol did not have similar effects on ex-
pression of TGFb isoforms as retinoic acid. Retinol did not
increase expression of any TGFb isoforms after 24 h. How-
ever, after 72 h of treatment retinol increased expression of
TGFb1 and TGFb2, but did not effect mRNA expression of
TGFb3. These differences are presumably do to conversion
of retinol into both all-trans and 9-cis retinoic acid which act
at both RAR (all-trans and 9-cis) and RXR (9-cis).
FSH did not stimulate expression of mRNA for any TGFb
isoform. This supports previous reports that FSH stimulation
of P0 testis does not influence expression of TGFb isoforms
(20). FSH treatment in combination with retinoic acid ap-
peared to inhibit the ability of retinoic acid to stimulate
TGFb1 and TGFb3 isoform expression. After 72 h, expression
of TGFb1 was suppressed in a retinoic acid and FSH com-
bined treatment when compared with retinoic acid treatment
alone. In addition, the expression of TGFb3 was also altered
when retinoic acid was given in combination with FSH.
Therefore, FSH may alter the ability of retinoic acid to stim-
ulate expression of TGFb isoforms in P0 testis cultures.
Knockout mice lacking RARs demonstrate that retinoids
are important for testis development. RARa knockout mice
are sterile due to defective spermatogenesis (40). RARg
knockouts have problems associated with secondary sex
glands, which is not associated with testis development but
may alter viability of sperm (41). However, no problems have
been detected in embryonic testis development in these
knockouts. The redundant nature of the RARs may allow for
compensation to occur in mice lacking one of the RAR genes
or retinoic acid may only be important in later testis
development.
In conclusion, the novel results of the current study dem-
onstrate that retinoic acid or an RAR-specific agonist can
FIG. 9. Effects of retinoic acid on relative amounts of mRNA for (A)
TGFb1, (B) TGFb2, and (C) TGFb3 after 24 or 72 h of treatment.
Amounts of mRNA for TGFb isoforms were normalized to cyclophilin
(1B15) and expressed relative to controls. These data represent three
individual experiments assayed in duplicate. Different superscript
letters for each mean represent a statistical differences at P , 0.05.
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influence the process of seminiferous cord formation. The
potential absence of RAR isoforms at E14 and the presence
of RAR isoforms after E16 in testis development suggests that
retinoic acid is not necessary for seminiferous cord forma-
tion. Because seminiferous cord formation is disrupted by
high doses of retinoic acid and RAR specific agonists the lack
of RARs may be a protective mechanism to ensure successful
testis development. The primary function of retinoic acid
may be to allow for cell differentiation and growth in the
interstitium and germ cells after E16. The localization of the
RARs in P0 testis is interesting because all receptors are
present within the germ cell population. This suggests that
retinoic acid may be critical to germ cell development. At P0,
the germ cells in the testis are in mitotic arrest, and retinoic
acid may be involved in initiating this process to allow for
germ cell differentiation. The current study also presents
novel information on potential mechanisms for retinoid reg-
ulation of testis cell growth. The mechanism for retinoid
regulation of cell growth is proposed to be through increased
expression of TGFb isoforms. Therefore, retinoids appear to
be important during perinatal testis development to regulate
cellular growth and differentiation.
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